NASDAQ : KMTS

Kestra Medical Technologies, Ltd. — Financial statements

Healthcare · Medical Instruments & Supplies · United States

Last price 30.61 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 1.82B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Financial statements

Kestra Medical Technologies, Ltd. (KMTS) reported revenue of 106.73M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.

Income statement

Fiscal year May - April; amounts in USD.

TTMFY2026FY2025FY2024FY2023FY2021
Revenue106.73M95.13M59.81M27.81M7.63M
Cost of Revenue49.22M46.26M35.60M27.45M18.28M
Gross Profit57.51M48.86M24.21M362.00K-10.65M
Selling, General & Admin178.75M164.12M114.94M69.94M54.01M13.90M
Research & Development22.28M19.48M15.65M15.49M15.76M18.81M
Operating Expenses201.03M183.60M130.59M85.42M69.77M32.71M
Operating Income-143.52M-134.74M-106.38M-85.06M-80.42M-32.71M
Interest Expense-7.56M-7.55M-7.73M-6.23M-5.63M-1.17M
Interest & Investment Income8.31M8.35M3.20M
Other Non Operating Income (Expenses)-484.00K2.62M-2.77M-87.00K1.83M-38.00K
EBT Excluding Unusual Items-143.26M-131.32M-113.68M-91.38M-84.22M-33.91M
Other Unusual Items-6.30M-2.72M
Pretax Income-149.56M-131.32M-113.68M-94.10M-84.22M-33.91M
Income Tax Expense311.00K294.00K135.00K24.00K15.00K187.00K
Net Income-149.87M-131.61M-113.81M-94.12M-84.24M-34.10M
Preferred Dividends & Other Adjustments12.32M6.72M2.50M
Net Income to Common-149.87M-131.61M-126.14M-100.84M-86.74M-34.10M
Shares Outstanding (Basic)56.00M54.18M24.58M19.89M105.81K105.81K
Shares Outstanding (Diluted)56.00M54.18M24.58M19.89M105.81K105.81K
EPS (Basic)-2.68-2.43-5.13-5.07-819.76-322.29
EPS (Diluted)-2.68-2.43-5.13-5.07-819.76-322.29
Free Cash Flow-123.21M-117.12M-101.20M-84.75M-85.10M-30.23M
Free Cash Flow Per Share-2.20-2.16-4.12-4.26-804.32-285.72
Gross Margin53.89%51.37%40.48%1.30%-139.59%
Operating Margin-134.47%-141.65%-177.84%-305.83%-1,054.01%
Profit Margin-140.43%-138.36%-210.88%-362.56%-1,136.79%
Free Cash Flow Margin-115.44%-123.12%-169.19%-304.70%-1,115.37%
EBITDA-134.18M-126.03M-98.41M-73.50M-75.57M-32.29M
EBITDA Margin-125.72%-132.49%-164.52%-264.27%
D&A For EBITDA9.35M8.71M7.97M11.56M4.86M420.00K
EBIT-143.52M-134.74M-106.38M-85.06M-80.42M-32.71M
EBIT Margin-134.47%-141.65%-177.84%

Balance sheet

Fiscal year May - April; amounts in USD.

TTMFY2026FY2025FY2024FY2023FY2021
Cash & Equivalents68.56M99.71M237.59M8.25M14.81M24.34M
Short-Term Investments130.35M96.72M
Cash & Short-Term Investments198.91M196.43M237.59M8.25M14.81M24.34M
Receivables15.41M14.54M8.08M2.00M
Inventory7.44M6.71M6.57M3.29M2.11M
Prepaid Expenses2.39M1.69M1.39M951.00K1.13M509.00K
Other Current Assets2.12M2.98M1.69M419.00K370.00K1.34M
Total Current Assets226.27M222.36M255.33M14.91M18.42M26.20M
Property, Plant & Equipment66.92M62.45M36.91M28.39M16.72M3.08M
Long-Term Investments50.79M70.77M
Other Long-Term Assets3.37M2.88M3.51M2.65M3.51M1.24M
Total Assets347.36M358.46M295.74M45.95M38.66M30.52M
Accounts Payable25.96M27.30M23.96M23.89M6.16M1.70M
Accrued Expenses22.29M23.05M13.83M9.08M8.77M3.81M
Current Portion of Long-Term Debt20.45M
Current Portion of Leases23.00K31.00K187.00K1.37M1.06M
Current Income Taxes Payable42.00K
Total Current Liabilities48.27M50.37M37.98M32.97M36.74M6.61M
Long-Term Debt72.50M42.65M41.10M42.54M17.32M20.24M
Long-Term Leases3.93M4.11M3.03M2.63M1.55M
Other Long-Term Liabilities306.00K1.68M8.24M76.00K63.00K360.00K
Total Liabilities125.00M98.81M90.34M78.22M54.12M28.76M
Common Stock59.27M58.38M51.35M19.91M1.00K1.00K
Additional Paid-In Capital859.50M853.35M674.31M177.15M194.74M171.84M
Retained Earnings-695.95M-651.86M-520.25M-406.44M-312.31M-170.08M
Comprehensive Income & Other-471.00K-218.00K
Total Common Equity222.36M259.66M205.41M-209.38M-117.58M1.77M
Shareholders' Equity222.36M259.66M205.41M-32.27M-15.47M1.77M
Total Liabilities & Equity347.36M358.46M295.74M45.95M38.66M30.52M
Total Debt76.45M46.79M44.31M45.17M39.13M22.85M
Net Cash (Debt)122.47M149.64M193.28M-36.92M-24.32M1.49M
Net Cash Per Share2.192.767.86-1.86-229.8914.11
Filing Date Shares Outstanding59.56M58.60M51.35M105.81K105.81K105.81K
Total Common Shares Outstanding59.27M58.38M51.35M105.81K105.81K105.81K
Working Capital178.00M171.99M217.35M-18.06M-18.32M19.59M
Book Value Per Share3.754.454.00-1,978.84-1,111.2416.69
Tangible Book Value222.36M259.66M205.41M-209.38M-117.58M1.77M
Tangible Book Value Per Share3.754.454.00-1,978.84-1,111.2416.69
Machinery95.07M88.06M57.23M39.66M20.26M871.00K
Construction In Progress1.53M1.54M635.00K1.66M
Leasehold Improvements919.00K919.00K919.00K891.00K872.00K414.00K

Cash flow statement

Fiscal year May - April; amounts in USD.

TTMFY2026FY2025FY2024FY2023FY2021
Net Income-149.87M-131.61M-113.81M-94.12M-84.24M-34.10M
Depreciation & Amortization9.35M8.71M7.97M11.56M4.86M420.00K
Other Amortization1.81M1.87M1.40M610.00K446.00K151.00K
Loss (Gain) From Sale of Assets1.17M1.16M1.34M1.07M560.00K-2.00K
Stock-Based Compensation38.58M33.64M24.27M1.49M1.21M1.86M
Provision & Write-off of Bad Debts1.17M2.60M2.69M500.00K
Other Operating Activities9.82M148.00K4.74M2.77M6.23M1.79M
Change in Accounts Receivable-7.33M-9.06M-8.78M-2.50M
Change in Inventory-906.00K-458.00K-3.44M-1.18M-733.00K
Change in Accounts Payable5.32M4.30M2.84M7.34M2.14M-132.00K
Change in Other Net Operating Assets3.17M6.99M3.17M223.00K-112.00K113.00K
Operating Cash Flow-87.72M-81.70M-77.61M-72.23M-69.64M-29.89M
Capital Expenditures-35.49M-35.42M-23.59M-12.51M-15.46M-336.00K
Sale of Property, Plant & Equipment2.00K
Investment in Securities-181.06M-168.04M
Other Investing Activities147.00K184.00K283.00K285.00K
Investing Cash Flow-216.40M-203.28M-23.31M-12.23M-15.46M-334.00K
Long-Term Debt Issued45.00M20.00M
Long-Term Debt Repaid-39.12M-5.33M
Net Debt Issued (Repaid)24.85M5.88M-5.33M20.00M
Issuance of Common Stock152.32M149.88M218.16M30.33M
Other Financing Activities-4.69M-2.79M8.70M-3.15M-671.00K-1.52M
Financing Cash Flow171.47M147.09M330.26M77.72M96.11M48.81M
Net Cash Flow-132.66M-137.88M229.35M-6.74M11.00M18.59M
Free Cash Flow-123.21M-117.12M-101.20M-84.75M-85.10M-30.23M
Free Cash Flow Margin-115.44%-123.12%-169.19%-304.70%-1,115.37%
Free Cash Flow Per Share-2.20-2.16-4.12-4.26-804.32-285.72
Levered Free Cash Flow-72.03M-75.76M-67.53M-40.92M-18.53M
Unlevered Free Cash Flow-69.12M-72.92M-64.09M-37.63M-17.95M
Cash Interest Paid5.32M5.64M4.85M3.63M
Cash Income Tax Paid76.00K13.00K83.00K-30.00K12.00K214.00K
Change in Working Capital254.00K1.78M-6.20M3.89M1.30M-19.00K

Ratios

Fiscal year May - April; amounts in USD.

TTMFY2026FY2025FY2024FY2023FY2021
Market Capitalization1.78B1.21B1.24B
Enterprise Value1.65B964.72M1.52B
Last Close Price29.6920.7224.06
PS Ratio16.7312.7120.65
PB Ratio7.914.666.01
P/TBV Ratio8.034.666.01
EV/Sales Ratio15.5810.1425.48
Debt / Equity Ratio0.340.180.22-1.40-2.5312.94
Net Debt / Equity Ratio-0.55-0.58-0.94-1.14-1.57-0.84
Net Debt / EBITDA Ratio0.911.191.96-0.50-0.320.05
Net Debt / FCF Ratio0.991.281.91-0.44-0.290.05
Asset Turnover0.350.290.350.66
Inventory Turnover6.916.977.2210.16
Quick Ratio4.444.196.470.310.403.68
Current Ratio4.694.416.720.450.503.96
Return on Equity (ROE)-73.73%-56.60%-131.47%-1,212.91%
Return on Assets (ROA)-29.23%-25.75%-38.92%-125.68%-106.49%
Return on Capital Employed (ROCE)-48.00%-43.70%-41.30%-655.40%-4,195.10%-136.80%
Earnings Yield-8.97%-10.88%-9.21%
FCF Yield-6.90%-9.68%-8.19%
Buyback Yield / Dilution-72.64%-120.41%-23.63%-18,693.84%